Clinical Trials Browser

Interventional × Neoplasms × maltodextrin × Clear all

NCT02819960 2022-12-14

Prevention of Irinotecan Induced Diarrhea by Probiotics

Phase 3 Completed

Diarrhea, Neoplasms